A Phase 1 Open-Label, Repeat Dose Study to Assess the Pharmacokinetics, Safety and Tolerability Following Administration of Elafibranor in Healthy Japanese and Non-Asian Participants - Global

A Phase 1 Open-Label, Repeat Dose Study to Assess the Pharmacokinetics, Safety and Tolerability Following Administration of Elafibranor in Healthy Japanese and Non-Asian Participants

Back

A Phase 1 Open-Label, Repeat Dose Study to Assess the Pharmacokinetics, Safety and Tolerability Following Administration of Elafibranor in Healthy Japanese and Non-Asian Participants

- 29 January 2025 - 0 mins read
A Phase 1 Open-Label, Repeat Dose Study to Assess the Pharmacokinetics, Safety and Tolerability Following Administration of Elafibranor in Healthy Japanese and Non-Asian Participants

Related Documents

Related Lay Languages

An Open-label Study of Cabozantinib as 2nd Line Treatment in Subjects with Unresectable, Locally Advanced or Metastatic Renal Cell Carcinoma With a Clear-Cell Component Who Progressed After 1st Line Treatment With Checkpoint Inhibitors
29 January 2025 0 mins read

An Open-label Study of Cabozantinib as 2nd Line Treatment in Subjects with Unresectable, Locally Advanced or Metastatic Renal Cell Carcinoma With a Clear-Cell Component Who...
An Open Label Efficacy and Safety Study of Palovarotene in the Treatment of Preosseous Flare-ups in Subjects with Fibrodysplasia Ossificans Progressiva (FOP)
29 January 2025 0 mins read

An Open Label Efficacy and Safety Study of Palovarotene in the Treatment of Preosseous Flare-ups in Subjects with Fibrodysplasia Ossificans Progressiva (FOP)
Lipisomal irinotecan compared to standard treatment
08 November 2024 1 mins read

Lipisomal irinotecan compared to standard treatment
A study to learn about the efficacy and safety of triptorelin 6-month formulation in Chinese children with central precocious puberty
09 August 2024 0 mins read

A study to learn about the efficacy and safety of triptorelin 6-month formulation in Chinese children with central precocious puberty
A study to learn about the effect of strong CYP3A4 boosters or blockers on blood levels of tazemetostat (EPZ-6438) in patients with advanced cancer
09 August 2024 0 mins read

A study to learn about the effect of strong CYP3A4 boosters or blockers on blood levels of tazemetostat (EPZ-6438) in patients with advanced cancer
A study in healthy Japanese and non-Asian volunteers to understand what happens to elafibranor in the body when taken by Japanese people compared to non-Asian people
09 August 2024 1 mins read

A study in healthy Japanese and non-Asian volunteers to understand what happens to elafibranor in the body when taken by Japanese people compared to non-Asian...
A study comparing the muscle action potential effects in the foot muscle in healthy male volunteers
09 August 2024 1 mins read

A study comparing the muscle action potential effects in the foot muscle in healthy male volunteers
A study to evaluate the effects of the treatment in patients living with spastic hemiparesis in combination with a prescribed personal rehabilitation program
09 August 2024 1 mins read

A study to evaluate the effects of the treatment in patients living with spastic hemiparesis in combination with a prescribed personal rehabilitation program
A study on the effectiveness of the treatment for patients with non-functioning neuroendocrine tumours of the pancreas, intestines or unknown origin.  
09 August 2024 1 mins read

A study on the effectiveness of the treatment for patients with non-functioning neuroendocrine tumours of the pancreas, intestines or unknown origin.  
A Study to Learn About the Effect of Food on the Levels of Elafibranor in the Blood of Healthy Volunteers
09 August 2024 1 mins read

A Study to Learn About the Effect of Food on the Levels of Elafibranor in the Blood of Healthy Volunteers